Steven Cohen’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
Other funds holding RNAC
6CM
Steven Cohen's RNAC Position: Q3 2026 in Review
Steven Cohen increased its Cartesian Therapeutics (RNAC) stake by 9.5% in Q3 2026, buying an estimated $36.2K and bringing the position to 47,783 shares worth $345K. The position accounts for ﹤0.01% of the portfolio, ranked #3284.
Steven Cohen first reported a position in RNAC in Q2 2017 and has held it in 8 quarters since. The position peaked at $2.84M in Q2 2020. 100 funds tracked by Wall St. Rank hold RNAC as of Q3 2026.
- Steven Cohen held 47,783 shares of Cartesian Therapeutics worth $345K as of Q3 2026.
- Steven Cohen bought 4,156 Cartesian Therapeutics shares in Q3 2026, an estimated $36.2K.
- Cartesian Therapeutics made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #3284 holding.
- Steven Cohen first reported a position in Cartesian Therapeutics in Q2 2017 and has held it in 8 quarters since.
- Steven Cohen's Cartesian Therapeutics position peaked at $2.84M in Q2 2020.
- 100 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.